We are live on ! Find out more
DA

Dillon & Associates Portfolio holdings

AUM $726M
1-Year Est. Return 18.59%
This Fund
S&P 500
This Quarter Est. Return
+12.32%
1 Year Est. Return
+18.59%
3 Year Est. Return
+92.03%
5 Year Est. Return
+130.73%
10 Year Est. Return
+511.58%
AUM
$737M
AUM Growth
+$63.6M
Cap. Flow
+$1.37M
Cap. Flow %
0.19%
Top 10 Hldgs %
57.92%
Holding
79
New
1
Increased
35
Reduced
39
Closed
2

Top Buys

Rank Stock Value
1
ETN icon
Eaton
ETN
+$2.11M
2
CASY icon
Casey's General Stores
CASY
+$1.56M
3
COST icon
Costco
COST
+$1.47M
4
FISV
Fiserv Inc
FISV
+$1.35M
5
LLY icon
Eli Lilly
LLY
+$1.33M

Top Sells

Rank Stock Value
1
PEP icon
PepsiCo
PEP
+$2.56M
2
NVDA icon
NVIDIA
NVDA
+$2.4M
3
STZ icon
Constellation Brands
STZ
+$2.24M
4
ROK icon
Rockwell Automation
ROK
+$1.26M
5
GNRC icon
Generac Holdings
GNRC
+$454K

Sector Composition

Rank Sector Weight
1 Technology 41.44%
2 Healthcare 17.21%
3 Consumer Discretionary 13.09%
4 Communication Services 7.51%
5 Financials 6.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CRM icon
26
Salesforce
CRM
$151B
$8.4M 1.14%
30,764
+1,334
+5% +$357K
SBUX icon
27
Starbucks
SBUX
$120B
$7.93M 1.08%
86,169
-1,910
-2% -$166K
CNI icon
28
Canadian National Railway
CNI
$76.9B
$7.75M 1.05%
74,528
+630
+0.9% +$64.1K
REGN icon
29
Regeneron Pharmaceuticals
REGN
$78.5B
$7.01M 0.95%
13,344
-392
-3% -$219K
PAYX icon
30
Paychex
PAYX
$41.6B
$6.84M 0.93%
47,197
-1,684
-3% -$254K
ETN icon
31
Eaton
ETN
$161B
$6.68M 0.91%
18,724
+6,845
+58% +$2.11M
PEP icon
32
PepsiCo
PEP
$190B
$6.19M 0.84%
46,881
-19,017
-29% -$2.56M
RTX icon
33
RTX Corp
RTX
$290B
$5.61M 0.76%
38,407
+507
+1% +$67.6K
NEE icon
34
NextEra Energy
NEE
$181B
$4.71M 0.64%
68,246
+5,261
+8% +$365K
JPM icon
35
JPMorgan Chase
JPM
$935B
$4.59M 0.62%
15,824
-164
-1% -$41.9K
HD icon
36
Home Depot
HD
$331B
$4.16M 0.56%
11,324
-333
-3% -$121K
JNJ icon
37
Johnson & Johnson
JNJ
$618B
$3.69M 0.5%
24,093
-76
-0.3% -$11.7K
LLY icon
38
Eli Lilly
LLY
$1.02T
$3.3M 0.45%
4,228
+1,706
+68% +$1.33M
PG icon
39
Procter & Gamble
PG
$336B
$2.9M 0.39%
18,273
-575
-3% -$93.9K
MCD icon
40
McDonald's
MCD
$192B
$2.77M 0.38%
9,491
-83
-0.9% -$25.6K
CL icon
41
Colgate-Palmolive
CL
$73.1B
$2.76M 0.37%
30,317
-50
-0.2% -$4.57K
MNST icon
42
Monster Beverage
MNST
$94.3B
$2.56M 0.35%
40,577
-499
-1% -$30.5K
GNRC icon
43
Generac Holdings
GNRC
$11.6B
$1.87M 0.25%
13,059
-3,719
-22% -$454K
ADBE icon
44
Adobe
ADBE
$99.5B
$1.83M 0.25%
4,734
+545
+13% +$210K
AZN icon
45
AstraZeneca
AZN
$263B
$1.76M 0.24%
12,598
+507
+4% +$71.1K
WMT icon
46
Walmart Inc
WMT
$885B
$1.64M 0.22%
16,694
+91
+0.5% +$8.67K
HON icon
47
Honeywell
HON
$77B
$1.61M 0.22%
7,324
-579
-7% -$117K
MDLZ icon
48
Mondelez International
MDLZ
$79.5B
$1.33M 0.18%
19,925
-2,405
-11% -$160K
ABBV icon
49
AbbVie
ABBV
$443B
$1.31M 0.18%
7,041
+227
+3% +$42.2K
SYY icon
50
Sysco
SYY
$40.8B
$1.27M 0.17%
16,758
-801
-5% -$58.2K

Similar funds

Dillon & Associates's Q2 2025 Portfolio in Review

As of Q2 2025, Dillon & Associates held 79 positions worth $737M, up 9.4% from $673M the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Trading was light in Q2 2025: portfolio turnover was 3.8%. Dillon & Associates opened 1 new position and exited 2, leaving the 79-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 41% of assets, up from 39% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Dillon & Associates's largest Q2 2025 buy was ImmunityBio: 25,800 shares worth $77K.
  • Dillon & Associates added most to Eaton in Q2 2025, an estimated $2.11M increase.
  • Dillon & Associates's biggest Q2 2025 reduction was PepsiCo, cutting an estimated $2.56M.
  • Dillon & Associates fully exited Target in Q2 2025, selling an estimated $263K.
  • Dillon & Associates's ten largest holdings make up 58% of its $737M portfolio in Q2 2025.
  • Dillon & Associates opened 1 new position and closed 2 in Q2 2025.
  • Dillon & Associates's portfolio value rose 9.4% quarter-over-quarter to $737M.

Based on Dillon & Associates's 13F filing for Q2 2025, filed 5 Aug 2025.